铁蔗糖
平均红细胞体积
医学
贫血
缺铁
缺铁性贫血
血红蛋白
铁蛋白
胃肠病学
内科学
平均红细胞血红蛋白
补血的
平均红细胞血红蛋白浓度
静脉注射铁
外科
作者
Mehmet Fatih Orhan,Mustafa Büyükavcı
标识
DOI:10.1097/mph.0000000000002550
摘要
Iron deficiency anemia in children is a public health problem. Although oral iron treatment is the first choice, common side effects and compliance problems can cause the treatment to be interrupted. This study retrospectively evaluated children treated with intravenous (IV) iron sucrose or ferric carboxymaltose (FCM) and compared the treatment processes and efficacy. The demographic characteristics and treatment details of the 44 children with iron deficiency anemia were retrospectively evaluated. Iron sucrose was administered to 25 patients and FCM was administered to 19 patients. The IV iron infusion was applied to 64% of the patients because of unresponsiveness to oral treatment, 25% of the patients because of compliance problems, and 11% of the patients because of severe anemia. IV iron therapy increased hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, red-cell distribution width, and serum ferritin levels and decreased platelet count. The mean number of infusions per patient in the FCM group was lower, and the total treatment time was shorter. In conclusion, IV iron sucrose or FCM can be used in children with nonadherence to oral therapy and severe anemia in addition to specific indications.
科研通智能强力驱动
Strongly Powered by AbleSci AI